Valuation: Zalicus Inc

Market Cap 746K 649K 606K 556K 1.05M 71.13M 1.07M 7.14M 2.8M 35.47M 2.8M 2.74M 117M P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -15.94M -13.85M -12.93M -11.87M -22.38M -1.52B -22.77M -152M -59.71M -757M -59.86M -58.53M -2.5B EV / Sales 2014
14,770,294,750x
EV / Sales 2015 83,658,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+0.14%-2.06%+14.33% 48.22B
-2.71%-2.99%+398.09%+472.12% 38.79B
-0.71%+9.45%+27.90%+7.89% 38.41B
-0.71%-3.72%+4.94%+52.45% 34.88B
-2.41%+1.96%+11.68%+38.17% 29.19B
-0.66%-2.73%+35.50%+122.17% 16B
-0.19%-3.93% - - 16.05B
-0.62%+1.23%+2.76%+15.05% 13.53B
-3.15%-6.14%-4.82%-36.90% 12.22B
Average -1.28%-0.66%+59.25%+85.66% 27.48B
Weighted average by Cap. -1.23%+0.15%+75.56%+103.60%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.01 0.19 0.02 0.01 0.63 0.7 0.61 0.57 0.52 0.98 66.82 1 6.71 2.63 33.32 2.63 2.57 109.9
Net income -41.84M -36.37M -33.95M -31.17M -58.77M -3.99B -59.8M -400M -157M -1.99B -157M -154M -6.56B -52.19M -45.36M -42.35M -38.87M -73.3M -4.97B -74.58M -499M -196M -2.48B -196M -192M -8.18B
Net Debt -14.18M -12.32M -11.51M -10.56M -19.92M -1.35B -20.26M -136M -53.13M -674M -53.26M -52.08M -2.22B -16.68M -14.5M -13.54M -12.43M -23.43M -1.59B -23.84M -160M -62.51M -793M -62.66M -61.27M -2.62B
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-